According to our latest research, the global Polycystic Ovarian Syndrome (PCOS) Treatment market size reached USD 4.52 billion in 2024, reflecting steady growth driven by increased awareness, improved diagnostic capabilities, and a rising prevalence of PCOS worldwide. The market is expected to expand at a CAGR of 5.8% from 2025 to 2033, reaching a forecasted value of USD 7.56 billion by 2033. This growth is primarily attributed to advancements in treatment modalities, the growing burden of lifestyle-related disorders, and the increasing focus on women’s reproductive health across both developed and emerging economies.